Long-Term Clean Intermittent Catheterization, Chronic Inflammation and Cancer: A Case Report and Review
In areas not endemic for schistosomiasis, the development of squamous cell carcinoma of the bladder (bSCC) is commonly associated with long-term indwelling catheterization (LTIC) and its associated bladder inflammation. Today, many patients unable to void use clean intermittent catheterization (CIC), a practice which gained popularity over the last 2-3 decades. Historically, CIC has not been perceived as a potential risk factor for bSCC; yet we believe that for many of the same reasons LTIC creates a hostile inflammatory environment potentially resulting in bSCC, CIC may also lead to bSCC, albeit at a slower pace. Using our interesting case as a starting point, we reviewed LTIC-related inflammatory mechanisms and drew connections between these mechanisms and CIC in an effort to raise awareness of the possible link to bSCC as the number of patients practicing CIC over multiple decades continues to grow.
Introduction
Squamous cell carcinoma of the bladder (bSCC) arises in the setting of chronic bladder inflammation and is thus the most common bladder malignancy in areas endemic for Schistosomiasis [1]. Elsewhere, bSCC comprises less than 5% of all bladder cancer, most frequently in patients with spinal cord injuries [SCI] dependent on long-term indwelling catheterization (LTIC) [2]. This connection has been well established in the literature for almost 40 years [3].
Today, however, the gold standard for the management of neurogenic bladders is clean intermittent catheterization (CIC). Following its inception in 1972, usage in managing newly neurogenic bladders grew in popularity from 12% to around 50% from 1991 onward [4]. Time and research have demonstrated that practicing CIC, in many ways, results in better outcomes than those practicing LTIC; however, CIC does not come without its own risks, especially to those performing self- catheterization long-term. These risks include increased rates of urinary tract infections (UTI), traumatic catheterization and increased time of bladder exposure to irritants in the urine [5]. But rarely, if ever, listed amongst those maladies is an increased risk for bSCC. We report a unique and informative case highlighting this potential link in a patient who had performed CIC for 35 years in the absence of other risk factors commonly present in cases of bSCC.
Case Report
A 49-year-old female was seen in clinic for a symptomatic UTI and new onset hematuria when passing a catheter. The patient was diagnosed at birth with spina bifida, but suffered from no weakness or orthopedic abnormalities, walking into our clinic without the stigmata commonly associated with the condition. In fact, she had no functional impairment at all until she underwent back surgery at the age of 14 for spina bifida- associated chronic lower back pain. It was at this time the patient developed a neurogenic bladder which was drained by CIC up to three times per day without incident over the next 35 years. In the hematuria work-up, cystoscopy discovered a large, isolated bladder mass on the posterior wall which was found to be squamous cell carcinoma invading into the muscular layer of the bladder. The patient underwent a radical cystectomy, hysterectomy and bilateral salpingo-oophorectomy with an ideal conduit urinary diversion and bilateral pelvic lymph node dissection (Figure1). The patient tolerated the procedure well, but one lymph node on the left and one on the right were found to contain metastatic SCC. The patient was referred to an oncologist for chemotherapy.
Discussion
Chronic inflammation is associated with multiple cancers all over the body including skin, esophageal, gastric, pancreatic, liver, colon and bladder cancer. Although the exact mechanisms behind inflammatory tumorigenesis are yet to be elucidated, it has become evident that chronic inflammation creates an environment, rich in cytokines and growth factors, that favors cell proliferation, migration, angiogenesis and the suppression of apoptosis [6]. This inflammatory microenvironment potentially contributes to tumor development through induction of oncogenic mutations and genomic instability, all while acting in every step of tumor development-from initiation to metastasis [7]. Given this premise, the conclusion follows that LTIC may lead to bSCC as these patients are setups for chronic bladder inflammation due to both mechanical trauma and chronic UTIs. Local mechanical trauma and chronic irritation of the bladder epithelium from indwelling catheters, like schistosomiasis, are believed to promote the development of bladder cancer due to the induction of epithelial hyperplasia [8]. This trauma can be due to pressure damage from the catheter tip as the bladder drains and collapses around the catheter or from suction damage as the bladder wall is aspirated into the drainage eyelets [9, 10, 11]. Not only does this constant irritation promote a much localized chronic inflammatory response, but the mechanical trauma associated with long-term catheterization has been demonstrated to create alterations in histological architecture hypothesized to provide a route for both local spread and distant metastasis [8, 12]. Likewise, chronic UTIs have been associated with both chronic catheterization and bladder cancer and corroborate the connection between the two. In a recent case-control study using the data found in the Nijmegen Bladder Cancer Study, Vermeulen, et al found recurrent UTIs to have an odds ratio of developing bladder cancer of 6.6 in men and 2.7 in women [13]. Possible explanations for this link include the carcinogenic N-nitrosamines formed in the presence of nitrate-reducing bacteria and the up regulation of local nitric oxide production by the activation of inducible nitric oxide synthase which may promote tumor growth and proliferation [14, 15] Undoubtedly, local mechanical trauma and recurrent UTIs create perpetually inflamed bladders primed for tumorigenesis, yet these factors are not unique to LTIC— our patient presented with a symptomatic UTI and had performed CIC approximately 30,000 times over a 35- year span. Each catheterization provided not only an opportunity for infection but also for direct catheter trauma to the bladder, as evidenced by the tumor’s location directly opposite the urethral orifice through which catheters were passed (Figure 1).
![Figure 1: The large, isolated mass located on the posterior wall of the bladder found to be squamous cell carcinoma invading into the muscular layer. Also implicating the role of direct mechanical trauma in our patient was the fact that epithelial tissue distant from the tumor remained urothelial. This observation has been made in other cases of CIC leading to bSCC, and other authors have proposed this to be evidence of local trauma’s role in bSCC [16-20]. Similarly, UTIs are the most common complication in patients practicing CIC and increase over time the longer a patient practices CIC [5,21]. Distinct from LTIC, a third setup for chronic inflammation exists for long-term practitioners of CIC. Depending upon the duration between and effectiveness of each catheterization, urinary stasis similar to that which exists in bladder outlet obstruction, can be present. Bladder outlet obstruction has also been implicated in bladder cancer, as urinary stasis leads to a theoretical increase in contact between urinary irritants, potential carcinogens and the bladder epithelium leading to chronic inflammation [14]. Despite all of these inflammatory factors coalescing in this particular method of neurogenic bladder management, bSCC in the setting of CIC is difficult to find outside of case reports. One possible reason for this fact is that the inflammatory onslaught in the setting of LTIC is much more unrelenting than the frequent, punctuated insults of CIC. Because of this, the average time to tumorigenesis may be much greater in CIC than in LTIC. It took our patient 35 years of self-catheterization, so a timeline of multiple decades may be more likely. Considering that the use of CIC for bladder management in newly neurogenic bladders only began to approach 50% in 1991, some authors propose—and we agree—that we may just now begin to see more cases of bSCC related to CIC in our clinics and operating rooms [4,19].](/fulltextimages/427/fig_1.jpeg)
Figure 1: The large, isolated mass located on the posterior wall of the bladder found to be squamous cell carcinoma invading into the muscular layer. Also implicating the role of direct mechanical trauma in our patient was the fact that epithelial tissue distant from the tumor remained urothelial. This observation has been made in other cases of CIC leading to bSCC, and other authors have proposed this to be evidence of local trauma’s role in bSCC [16, 17, 18, 19, 20]. Similarly, UTIs are the most common complication in patients practicing CIC and increase over time the longer a patient practices CIC [5, 21]. Distinct from LTIC, a third setup for chronic inflammation exists for long-term practitioners of CIC. Depending upon the duration between and effectiveness of each catheterization, urinary stasis similar to that which exists in bladder outlet obstruction, can be present. Bladder outlet obstruction has also been implicated in bladder cancer, as urinary stasis leads to a theoretical increase in contact between urinary irritants, potential carcinogens and the bladder epithelium leading to chronic inflammation [14]. Despite all of these inflammatory factors coalescing in this particular method of neurogenic bladder management, bSCC in the setting of CIC is difficult to find outside of case reports. One possible reason for this fact is that the inflammatory onslaught in the setting of LTIC is much more unrelenting than the frequent, punctuated insults of CIC. Because of this, the average time to tumorigenesis may be much greater in CIC than in LTIC. It took our patient 35 years of self-catheterization, so a timeline of multiple decades may be more likely. Considering that the use of CIC for bladder management in newly neurogenic bladders only began to approach 50% in 1991, some authors propose—and we agree—that we may just now begin to see more cases of bSCC related to CIC in our clinics and operating rooms [4, 19].
Conclusion
Most patients diagnosed with bSCC will die within 1 to 3 years of diagnosis [2]. The poor prognosis of this disease is in large part due to its late presentation, so awareness of a potential link to those practicing CIC over multiple decades could be lifesaving. As was the case with our patient, up to 95% of patients present at an advanced stage with invasion to local organs or spread to pelvic lymph nodes; [22] thus in order to arrive at the earliest possible diagnosis, it is imperative to be aware of all patient populations with chronically inflamed bladders at risk of developing bSCC—especially those practicing LTIC and long-term CIC. This has proven to be easier said than done. Despite the known connection between bSCC and patients practicing LTIC, annual urine cytology alone has demonstrated to be ineffective for adequate surveillance and a healthy debate continues in the literature regarding the use of surveillance cystoscopies for bladder cancer in at risk populations [23, 24, 25, 26, 27]. If cystoscopy is the answer, effective surveillance cystoscopy guidelines will likely be decided by our ability to successfully risk-stratify LTIC and CIC patients according to inflammatory risk factors such as duration of LTIC, duration and frequency of CIC, chronicity of UTIs, presence of bladder calculi and urinary retention along with carcinogenic risk factors such as cigarette smoking.
References
-
Rausch S, Lotan Y, Youssef RF (2004) Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: A contemporary review with focus on nonbilharzial squamous cell carcinoma. Urol Oncol 32(1): 11-16.
-
Abol-Enein H, Kava BR, Carmack AJK (2007) Nonurothelial Cancer of the Bladder. Urology 69(1): 93-104.
-
Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, et al. (1977) Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118(6): 967-971.
-
Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, et al. (2010) Bladder Management After Spinal Cord Injury in the United States 1972 to 2005. J Urol 184(1): 213-217.
-
Wyndaele JJ (2002) Complications of intermittent catheterization: their prevention and treatment. Spinal Cord 40(10): 536-541.
-
Youssef R, Kapur P, Shariat SF, Arendt T, Kabbani W, et al. (2012) Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder. BJU Int 110(7): 961-966.
-
Grivennikov SI, Greten FR, Karin M (2010) Immunity, Inflammation, and Cancer. Cell 140(6): 883-899.
-
Thompson DB, Siref LE, Feloney MP, Hauke RJ, Agrawal DK (2015) Immunological Basis in the Pathogenesis and Treatment of Bladder Cancer. Expert Rev Clin Immunol 11(2): 265-279.
-
Glahn BE (1988) Influence of Drainage Conditions on Mucosal Bladder Damage by Indwelling Catheters: I. Pressure Study. Scand J Urol Nephrol 22(2): 87-92.
-
Glahn BE, Braendstrup O, Olesen HP (1988) Influence of Drainage Conditions on Mucosal Bladder Damage by Indwelling Catheters: II. Histological study. Scand J Urol Nephrol 22(2): 93-99.
-
Feneley RCL, Kunin CM, Stickler DJ (2012) An indwelling urinary catheter for the 21st century. BJU Int 109(12): 1746-1749.
-
Goble NM, Clarke T, Hammonds JC (1989) Histological changes in the urinary bladder secondary to urethral catheterisation. Br J Urol 63(4): 354-357.
-
Vermeulen SH, Hanum N, Grotenhuis AJ, Castan G, van der Heijden AG, et al. (2015) Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 112(3): 594-600.
-
Michaud DS (2007) Chronic inflammation and bladder cancer. Urol Oncol 25(3): 260-268.
-
Lin Z, Chen S, Ye C, Zhu S (2003) Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis. Urol Res 31(4): 232-235.
-
Sene AP, Massey JA, McMahon RTF, Carroll RNP (1990) Squamous cell carcinoma in a patient on clean intermittent self-catheterisation. Br J Urol 65(2): 213- 214.
-
Kaye MC, Levin HS, Montague DK, Pontes JE (1992) Squamous cell carcinoma of the bladder in a patient on intermittent self-catheterization. Cleve Clin J Med 59(6): 645-646.
-
Zaidi SZ, Theaker JM, Smart CJ (1997) Squamous cell carcinoma in a patient on clean intermittent self- catheterization. Br J Urol 80(2): 352-353.
-
Casey RG, Cullen IM, Crotty T, Quinlan DM (2009) Intermittent self-catheterization and the risk of squamous cell cancer of the bladder: An emerging clinical entity? Can Urol Assoc J 3(5): 51-54.
-
Shokeir AA (2004) Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int. 93(2): 216-220.
-
Wyndaele JJ, Brauner A, Geerlings SE, Bela K, Peter T, et al. (2012) Clean intermittent catheterization and urinary tract infection: review and guide for future research. BJU Int 110(11): E910-E917.
-
Serretta V, Pomara G, Piazza F, Gange E (2000) Pure Squamous Cell Carcinoma of the Bladder in Western Countries. Eur Urol 37(1): 85-89.
-
Stonehill WH, Goldman HB, Dmochowski RR (1997) The use of urine cytology for diagnosing bladder cancer in spinal cord injured patients. J Urol 157(6): 2112-2114.
-
El Masri WS, Patil S, Prasanna KV, Chowdhury JR (2014) To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question!. Spinal Cord 52(1): 49-53.
-
Colgate C, Derry F, Allison HC, van Middendorp JJ (2014) To cystoscope or not to cystoscope: Was that really the question? Spinal Cord. 52(6): 499.
-
Nahm LS, Chen Y, DeVivo MJ, Lloyd LK (2015) Bladder Cancer Mortality after Spinal Cord Injury over 4 Decades. J Urol 193(6): 1923-1928.
-
Elliott SP (2015) Screening for bladder cancer in individuals with spinal cord injury. J Urol 193(6): 1880-1881.
- Results of 6-Month Follow-Up of Patients After B-Turp and Thulep
- The Effect of Drinking Water with a High Content of Antimony and Arsenic on the Dynamics of their Distribution in the Kidneys and the Renal Excretory Function in Rats
- Effectiveness and Safety of Tansurethral Thulium Laser Enucleation of the Prostate in the Treatment of BPH: Review
- A Systematic Review on Molecular Pathophysiology Involved in Chronic Kidney Disease and the Role of Animal Models in Drug Discovery to Manage in Chronic Kidney Disease - An Update
- Functional Development of Kidneys in Human Ontogenesis
- Testicular Metastasis: Uncommon Prostate Cancer Case Report